Literature DB >> 19398380

Increased phosphorylation of extracellular signal-regulated kinase in trigeminal nociceptive neurons following propofol administration in rats.

Emi Shoda1, Junichi Kitagawa, Ikuko Suzuki, Ieko Nitta-Kubota, Makiko Miyamoto, Yoshiyuki Tsuboi, Masahiro Kondo, Yuji Masuda, Yoshiyuki Oi, Ke Ren, Koichi Iwata.   

Abstract

UNLABELLED: Although propofol (PRO) is widely used in clinic as a hypnotic agent, the underlying mechanisms of its action on pain pathways is still unknown. Sprague-Dawley rats were assigned to receive PRO or pentobarbital (PEN) and were divided into 2 groups as LIGHT and DEEP hypnotic levels based on the EEG analysis. Rats in each hypnotic level received capsaicin injection into the face and phosphorylated extracellular signal-regulated kinase (pERK) immunohistochemistry was performed in subnucleus caudalis (Vc) and upper cervical spinal cord. In the rats with PEN or PRO administration, a large number of pERK-like immunoreactive (LI) cells was observed in the trigeminal spinal subnuclei interpolaris and caudalis transition zone (Vi/Vc), middle Vc, and transition zone between Vc and upper cervical spinal cord (Vc/C2) following capsaicin injection into the whisker-pad region. The number of pERK-LI cells in Vi/Vc, middle Vc, and Vc/C2 was significantly larger in rats with PRO infusion than those with PEN infusion. The number of pERK-LI cells was increased following an increase in the dose of PRO but not in PEN. The pERK-LI cells were mainly distributed in the Vi/Vc, middle Vc, and Vc/C2 after the bolus infusion of PRO. The expression of pERK-LI cells was depressed after the intravenous lidocaine application before bolus PRO infusion. The present findings suggest that PRO induced an enhancement of the activity of trigeminal nociceptive pathways through nociceptors innervating the venous structure, as indicated by a lidocaine-sensitive increase in pERK. This may explain deep pain around the injection regions during intravenous bolus infusion of PRO. PERSPECTIVE: The effect of propofol administration on ERK phosphorylation in the subregions of the spinal trigeminal complex and upper cervical spinal cord neurons were precisely analyzed in rats with PRO infusion. A large number of pERK-LI cells was observed following intravenous PRO administration, suggesting an enhancement of trigeminal nociceptive activity and that PRO may produce pain through nociceptors innervating the venous structures during infusion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19398380      PMCID: PMC2697496          DOI: 10.1016/j.jpain.2008.11.013

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  52 in total

1.  Nociceptive-specific activation of ERK in spinal neurons contributes to pain hypersensitivity.

Authors:  R R Ji; H Baba; G J Brenner; C J Woolf
Journal:  Nat Neurosci       Date:  1999-12       Impact factor: 24.884

2.  Masseteric inflammation-induced Fos protein expression in the trigeminal interpolaris/caudalis transition zone: contribution of somatosensory-vagal-adrenal integration.

Authors:  H Imbe; R Dubner; K Ren
Journal:  Brain Res       Date:  1999-10-23       Impact factor: 3.252

3.  Screening for cerebroprotective agents using an in vivo model of cerebral reversible depolarization in awake rats.

Authors:  M Bodo; G Perjes; E Kalman; E Bacskai; K Berko; A Sarkadi; I Nagy; K L Keim; F M Matysik; K Csomor; R McCarron; Y Zagvazdin; M Rosenthal; C Morrissette; E Herendy; L Szporny; Z Nagy
Journal:  Pharmacol Res       Date:  2001-11       Impact factor: 7.658

4.  Microdialysis perfusion of 5-HT into hypoglossal motor nucleus differentially modulates genioglossus activity across natural sleep-wake states in rats.

Authors:  A Jelev; S Sood; H Liu; P Nolan; R L Horner
Journal:  J Physiol       Date:  2001-04-15       Impact factor: 5.182

5.  GABA(A) receptor-mediated effects on expression of c-Fos in rat trigeminal nucleus following high- and low-intensity afferent stimulation.

Authors:  M Takemura; T Shimada; Y Shigenaga
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

6.  Modulation of GABA(A) receptor channel gating by pentobarbital.

Authors:  J H Steinbach; G Akk
Journal:  J Physiol       Date:  2001-12-15       Impact factor: 5.182

7.  ERK MAP kinase activation in superficial spinal cord neurons induces prodynorphin and NK-1 upregulation and contributes to persistent inflammatory pain hypersensitivity.

Authors:  Ru-Rong Ji; Katia Befort; Gary J Brenner; Clifford J Woolf
Journal:  J Neurosci       Date:  2002-01-15       Impact factor: 6.167

8.  Induction of Fos protein-like immunoreactivity in the trigeminal spinal nucleus caudalis and upper cervical cord following noxious and non-noxious mechanical stimulation of the whisker pad of the rat with an inferior alveolar nerve transection.

Authors:  Hirofumi Nomura; Akiko Ogawa; Akimasa Tashiro; Toshifumi Morimoto; James W Hu; Koichi Iwata
Journal:  Pain       Date:  2002-02       Impact factor: 6.961

9.  Activin acutely sensitizes dorsal root ganglion neurons and induces hyperalgesia via PKC-mediated potentiation of transient receptor potential vanilloid I.

Authors:  Weiguo Zhu; Pin Xu; Fernando X Cuascut; Alison K Hall; Gerry S Oxford
Journal:  J Neurosci       Date:  2007-12-12       Impact factor: 6.167

10.  Propofol suppresses synaptic responsiveness of somatosensory relay neurons to excitatory input by potentiating GABA(A) receptor chloride channels.

Authors:  Shui-Wang Ying; Peter A Goldstein
Journal:  Mol Pain       Date:  2005-01-14       Impact factor: 3.395

View more
  2 in total

Review 1.  The role of trigeminal interpolaris-caudalis transition zone in persistent orofacial pain.

Authors:  Ke Ren; Ronald Dubner
Journal:  Int Rev Neurobiol       Date:  2011       Impact factor: 3.230

2.  Involvement of trigeminal transition zone and laminated subnucleus caudalis in masseter muscle hypersensitivity associated with tooth inflammation.

Authors:  Kohei Shimizu; Kunihito Matsumoto; Noboru Noma; Shingo Matsuura; Kinuyo Ohara; Hiroki Komiya; Tetsuro Watase; Bunnai Ogiso; Yoshiyuki Tsuboi; Masamichi Shinoda; Keisuke Hatori; Yuka Nakaya; Koichi Iwata
Journal:  PLoS One       Date:  2014-10-03       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.